لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Schiff D; Division of Neuro-Oncology, Neuro-Oncology Center, University of Virginia Health System, Charlottesville, Virginia., Jaeckle KA; Atlantic Health System, Summit, New Jersey., Anderson SK; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Galanis E; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Giannini C; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Buckner JC; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Stella P; Medical Oncology Program, St. Joseph Mercy Health System, Ann Arbor, Michigan., Flynn PJ; Metro Minnesota Community Clinical Oncology Program, St. Louis Park, Minnesota., Erickson BJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Schwerkoske JF; Minnesota Oncology, Woodbury, Minnesota., Kaluza V; Medical Oncology Program, St. Joseph Mercy Health System, Ann Arbor, Michigan., Twohy E; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Dancey J; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland., Wright J; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland., Sarkaria JN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.

المصدر: Cancer [Cancer] 2018 Apr 01; Vol. 124 (7), pp. 1455-1463. Date of Electronic Publication: 2018 Jan 03.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*drug therapy , Glioblastoma/*drug therapy , Neoplasm Recurrence, Local/*drug therapy, Adult ; Brain Neoplasms/pathology ; Female ; Follow-Up Studies ; Glioblastoma/pathology ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Sirolimus/administration & dosage ; Sirolimus/analogs & derivatives ; Sorafenib/administration & dosage ; Survival Rate

المؤلفون: Rifkin RM; US Oncology Research, Inc, The Woodlands, TX, USA. robert.rifkin@usoncology.com, Greenspan A, Schwerkoske JF, Mandanas RA, Stephenson JJ, Kannarkat GT, Zhan F, Boehm KA, Asmar L, Beveridge R

المصدر: Investigational new drugs [Invest New Drugs] 2012 Apr; Vol. 30 (2), pp. 714-22. Date of Electronic Publication: 2010 Oct 12.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Peripheral Blood Stem Cell Transplantation*, Antineoplastic Agents/*therapeutic use , Boronic Acids/*therapeutic use , Multiple Myeloma/*drug therapy , Multiple Myeloma/*surgery , Pyrazines/*therapeutic use, Aged ; Antineoplastic Agents/adverse effects ; Boronic Acids/adverse effects ; Bortezomib ; Chemotherapy, Adjuvant ; Chi-Square Distribution ; Disease Progression ; Disease-Free Survival ; Feasibility Studies ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Melphalan/therapeutic use ; Middle Aged ; Multiple Myeloma/mortality ; Myeloablative Agonists/therapeutic use ; Pyrazines/adverse effects ; Time Factors ; Transplantation, Autologous ; Treatment Failure ; United States

المؤلفون: Kuzel TM; Feinberg School of Medicine-Northwestern University, Chicago, IL 60611, USA. t-kuzel@northwestern.edu, Li S, Eklund J, Foss F, Gascoyne R, Abramson N, Schwerkoske JF, Weller E, Horning SJ

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2007 Dec; Vol. 48 (12), pp. 2397-402. Date of Electronic Publication: 2007 Oct 13.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1042-8194 (Print) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Diphtheria Toxin/*therapeutic use , Interleukin-2/*therapeutic use , Lymphoma, Non-Hodgkin/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Diphtheria Toxin/adverse effects ; Female ; Humans ; Interleukin-2/adverse effects ; Male ; Middle Aged ; Receptors, Interleukin-2/analysis ; Recombinant Fusion Proteins/adverse effects ; Recombinant Fusion Proteins/therapeutic use

المؤلفون: Ingalls ST, Schwerkoske JF, Forman WB, Hoppel CL

المصدر: Journal of chromatography [J Chromatogr] 1983 May 13; Vol. 274, pp. 366-71.

نوع المنشور: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0427043 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation: J Chromatogr Subsets: MEDLINE

مواضيع طبية MeSH: Salicylates/*blood, Chromatography, High Pressure Liquid ; Humans ; Salicylates/isolation & purification ; Salicylic Acid ; Solvents